AAIPharma Announces Appointment of Vice President of Pharmaceutical Business Development.WILMINGTON, N.C. -- AAIPharma Inc. announced today the appointment of Ninad Deshpanday, Ph.D. to the newly created position of Vice President of Pharmaceutical Business Development. In this role, Dr. Deshpanday will be responsible for all North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. business development activities in Pharmaceutical Development, including Analytical, Biotechnology, Formulations Development, GMP GMP (guanosine monophosphate): see guanine. Manufacturing and Clinical Trial Materials for both Oral and Parenteral parenteral /pa·ren·ter·al/ (pah-ren´ter-al) not through the alimentary canal, but rather by injection through some other route, as subcutaneous, intramuscular, etc. par·en·ter·al adj. 1. dosage forms A dosage form is the physical form of a dose of medication, such as a capsule or injection. The route of administration is dependent on the dosage form of a given drug. . Dr. Deshpanday brings to AAIPharma over fifteen years experience in pharmaceutical development. Prior to joining the Company, he was Vice President of Drug Product Development for Synta Pharmaceuticals, with responsibilities for all CM&C activities. Prior to this, he served Cardinal Health <includeonly></includeonly> Cardinal Health (NYSE: CAH) is a premier, global healthcare company dedicated to making healthcare safer and more productive. Overview Headquartered in Dublin, Ohio, Cardinal Health, Inc. as Technical Business Director for the Pharmaceutics division. Previously, Dr. Deshpanday held leadership positions at AAIPharma, including Senior Manager of Formulations Development and Global Product Director of Pharmaceutics. "Dr. Deshpanday possesses a unique combination of leadership skills and technical expertise in pharmaceutical development, and is a great addition to our business development team," stated Pete Megronigle, Senior Vice President of North American Business Development. "This appointment represents AAIPharma's continued focus on maximizing technical capabilities with regional effectiveness and broadening its position in the marketplace." About AAIPharma AAIPharma Inc. is a global provider of product development and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services to the pharmaceutical, biotechnology, and medical device industries. From a single test through a range of integrated service offerings, we create value to an industry in search of productivity and innovation. For more information on the Company, please visit AAIPharma's website at www.aaipharma.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion